Skip to content

menu

Mazina Law logo
HomeAboutOur PracticeOur TeamContact
Search
Close

Pharmacy & Healthcare Legal Blog

Pharmacy & Healthcare legal updates, news, and industry trends

specialty pharmacy

Subscribe to specialty pharmacy via RSS

Biosimilars – effect on specialty pharmacy

By Natalia Mazina on August 1, 2017
Posted in Drug Distribution & Wholesalers, Drug Pricing, Uncategorized

Biologics are the fastest growing and the most expensive class of drugs on the market. The current cost of biologics is between $50,000 to $250,000 for one year of treatment. FTC Press Release. The numbers are expected to increase even further. Congressional Research.

Biosimilars –on the other hand – are less expensive due…

RxPolicy

RxPolicy provides pharmacy policies and compliance documents

Stay Connected

RSS LinkedIn

About the Author

The attorney behind “Healthcare & Pharmacy Blog” and Mazina Law practice. Natalia is a tenacious regulatory counsel and outside-the-box thinker offering extensive experience to healthcare providers

Read More...

Topics

Archives

Recent Posts

  • Important requirements when reporting drug theft to DEA
  • Navigating 2026 Part D pharmacy reimbursements. Resources.
  • A new webinar on DEA audits
  • Confusion surrounds a required notice of California pharmacy closure
  • AstraZeneca demands confidential information from pharmacies

Pharmacy & Healthcare Legal Blog

Mazina Law logo
Mazina Law
100 Pine Street, Suite 1250
San Francisco, CA 94111-5235
Email: admin@pharmhealthlaw.com
RSS LinkedIn
DisclaimerPrivacy Policy

About the Firm

We are a full service healthcare law firm, working primary with pharmacy and pharmaceutical clients helping them to stay on top of their legal compliance, preserve their licensing, and build a strong legal foundation.

Read More...
Copyright © 2026, Mazina Law. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo